Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
Diabetic retinopathy or active retinal disease
There is no proven way to prevent facial fat loss while selectively losing fat elsewhere
76% of our respondents had already tried calorie restrictive diets, 70% and had tried exercise and 71% had tried weight loss groups, without success
GLP-1R triggers various intracellular signaling pathways, such as the cAMP/PKA and PI3K/Akt pathways, by binding to endogenous GLP-1 or exogenous agonists, resulting in the enhancement of insulin secretion, inhibition of glucagon secretion, as well as anti-inflammatory and antioxidant stress response
Note the date, dose, injection site, and any side effects for each administration